Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL

Int J Hematol. 1995 Jun;61(4):215-22. doi: 10.1016/0925-5710(95)00365-y.

Abstract

We report a patient from an endemic area of adult T-cell leukemia/lymphoma (ATLL), who developed lymphoma with features characteristic of Hodgkin's disease (HD). Large atypical Reed-Sternberg/Hodgkin's cells (RS/H cells) had a CD3-CD15+CD20-CD30+CD45RO- immunophenotype. Epstein-Barr virus (EBV) latent membrane protein and EBV-encoded small RNA were detected in the RS/H cells. The patient received C-MOPP/ABVD chemotherapy for the HD resulting in a partial response. However, relapse occurred and he died of disease progression associated with serious bacterial infection. Although serial lymph node biopsies revealed consistent presence of the EBV-positive RS/H cells, the background small lymphocytes showed progressive increase in pleomorphism and nuclear irregularity. The lymphocytes had the T-cell phenotype, CD3+CD4+CD7-CD8-. Southern blot analysis using DNA probes for the human T-cell lymphotrophic virus-I (HTLV-I) and the T-cell receptor beta-chain gene demonstrated expansion of the HTLV-I infected monoclonal T-cells with the disease progression. We concluded that the patient synchronously presented two independent lymphoproliferative disorders; EBV-associated HD and ATLL resulting from HTLV-I infection.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / analysis
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Fatal Outcome
  • Herpesviridae Infections / complications*
  • Herpesviridae Infections / virology
  • Herpesvirus 4, Human / isolation & purification*
  • Hodgkin Disease / complications*
  • Hodgkin Disease / drug therapy
  • Human T-lymphotropic virus 1 / isolation & purification*
  • Humans
  • Immunophenotyping
  • Japan / epidemiology
  • Leukemia-Lymphoma, Adult T-Cell / complications*
  • Leukemia-Lymphoma, Adult T-Cell / epidemiology
  • Lymph Nodes / pathology
  • Male
  • Middle Aged
  • Neoplastic Stem Cells / chemistry
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • RNA, Viral / analysis
  • Reed-Sternberg Cells / chemistry
  • Reed-Sternberg Cells / virology
  • Tumor Virus Infections / complications*
  • Tumor Virus Infections / virology
  • Vinblastine
  • Vincristine / administration & dosage
  • Viral Matrix Proteins / analysis
  • Virus Activation / drug effects

Substances

  • Antigens, CD
  • EBV-associated membrane antigen, Epstein-Barr virus
  • RNA, Viral
  • Viral Matrix Proteins
  • Bleomycin
  • Procarbazine
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • COPP protocol